CVS Pharmacy Inc. and several of its subsidiaries have agreed to pay $315 million to resolve a Justice Department lawsuit alleging the retail chain illegally dispensed highly addictive opioid medications.
The lawsuit, originally filed in 2024, accused the pharmacy giant of putting profits over patients by fulfilling prescriptions for massive quantities of opioids and other controlled substances that were deemed medically unnecessary. According to the government’s complaint, CVS’s dispensing practices came “at the expense of public health and safety.”
Associate Attorney General Stanley Woodward praised the resolution in a statement on Tuesday. He characterized the massive payout as a “significant milestone in the Justice Department’s efforts to combat the opioid epidemic by cracking down on pharmacies who unlawfully fulfill prescriptions for controlled substances.”
Despite agreeing to the $315 million settlement, CVS has strongly pushed back against the government’s characterization of its business practices. In a public statement, the company emphasized that its pharmacists are rigorously trained in the “safe and appropriate use of all medications” and consistently make the “best decisions on behalf of patients.”
As part of the finalized agreement, the settlement does not require CVS to admit to any legal wrongdoing or liability.


